step 11 semaglutide Design and Baseline Characteristics of STEP-HFpEF Program Evaluating in Patients With Obesity HFpEF Phenotype Efficacy and safety of once-weekly

If the patient has a history of hypoglycemia and is on insulin or a sulfonylurea in addition to the GLP-1, you may want to lean more conservative

GLP-1 receptor agonists like semaglutide and tirzepatide are peptide-based biologics

Is Ozempic a Weight Loss Drug

Shima Hadidchi, MD , offers this cutting-edge treatment to help patients achieve their weight loss goals

This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the metabolic matrix while promoting a stable, physiological recovery from chronic biological stressors

Semaglutide, a GLP-1 receptor agonist, has been widely prescribed for obesity and type 2 diabetes